The complex interaction between Alzheimer drivers and aging
阿尔茨海默病驱动因素与衰老之间复杂的相互作用
基本信息
- 批准号:9708308
- 负责人:
- 金额:$ 259.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAffectAgeAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAmyloidAntibodiesAntigensAstrocytesAstrocytosisAttentionAutopsyBrainCell AgingCell Differentiation processCell NucleusCell modelCellsCerebrovascular systemCharacteristicsCoculture TechniquesCollaborationsCollectionColombiaColombianComplexConsequentialismCytokine GeneCytoplasmDataData SetDefectDiseaseDominant Genetic ConditionsElderlyExpression ProfilingExtravasationFibroblastsFoundationsGene ExpressionGene MutationGlial Fibrillary Acidic ProteinHeadHumanImmunohistochemistryIndividualInflammationInterleukin-1 alphaInterleukin-1 betaInterleukin-6InternationalLinkLiteratureMarylandMediatingMendelian disorderMethodsMicrogliaModificationMutationNeuronsNew YorkNuclearNuclear EnvelopeOnset of illnessPECAM1 genePathologyPathway interactionsPatientsPericytesPhenotypePhosphorylationPopulationPositron-Emission TomographyPreparationPresenile Alzheimer DementiaPrevention trialPublishingRecording of previous eventsResearchResource DevelopmentRoleSamplingSmooth Muscle MyocytesStatistical Data InterpretationSynapsesSystemTNF geneTREM2 geneTechniquesTestingTextTissue BanksTissuesTravelUbiquitinationUnited States National Institutes of HealthUniversitiesVariantVascular Smooth MuscleVisitWorkage relatedalpha synucleinbasebrain tissuecell typecomplex data early onsetexperiencefamily managementgenome wide association studyimmunocytochemistryinduced pluripotent stem cellinflammatory markerloss of functionmicroscopic imagingmind controlneuroinflammationneuropathologynovelpresenilin-1protein TDP-43responsesingle cell analysissingle-cell RNA sequencingsynaptic functionsynucleintau Proteinstomography
项目摘要
The complex interaction between Alzheimer drivers and aging
Project Summary/Abstract (30 lines of text)
The greatest risk for Alzheimer’s disease is age. This extremely tight correlation with age has
no explanation. However, most of what know about Alzheimer’s comes from early onset cases.
We will utilize the 100 cases of early onset AD stored in the Colombian brain bank all with the
same PSEN1[E280A] mutation to determine the full range of pathology observed due to a
monogenic defect and compare these data to sporadic older onset disease. Some of the
Colombian individuals in the bank have had amyloid and tau PET studies. In sporadic disease
among the elderly, brain changes related to aging are frequent and in the absence of their
clear delineation, treatments targeted solely at dominant genetic forms of the disease may be
ineffective. Factors which might distinguish and promote AD in the elderly include inflammation,
compromised brain vasculature, excessive microgliosis, cellular aging such as break down of
the nuclear membrane and consequently escape of TDP-43 from the nucleus and possible
contributions of synuclein. We will explore interactions of these factors with aging through
descriptive neuropathology and experimental neuropathology methods. Comparisons will utilize
sporadic AD post-mortem from several brain banks. These studies include state of the art
single cell RNAseq and advanced assessment of inflammation markers. Cellular models will be
explored using human induced pluripotent stem cell-derived neurons that harbor the
PSEN1[E280A] mutation and are intended to discover downstream pathways affected by the
mutation. Co-cultures with microglia to capture autonomous and non-autonomous effects of the
mutation will be determined.
To accomplish the aims we have assembled a multi-institutional international team with a long
history of collaboration. Dr. Lopera, who first recognized the families and manages the
Alzheimer Prevention Trial, heads the team in Colombia, an NIH supported project. To support
the neuropathology effort we have enlisted the expertise of Dr. Eric Huang. Kosik has a nearly
30 year collaboration with Lopera, is familiar with the conduct of research in Colombia and
recently traveled to visit the Colombian brain bank with Eric Huang. Kosik is closely connected
institutionally with UCSF through his role as co-director of the Tau Consortium along with Bruce
Miller. Kosik has published with Ellisman and serves on the review board for the National
Center for Microscopy and Imaging Research center at UCSD. Thus the project consists of a
strong, experienced and highly integrated team capable of conducting a complex project and
dealing with any of the obstacles that will inevitably arise.
阿尔茨海默病驱动因素与衰老之间复杂的相互作用
项目摘要/摘要(30 行文本)
阿尔茨海默病的最大风险是年龄。这种与年龄极其紧密的相关性
没有解释。然而,对阿尔茨海默氏症的了解大多来自早期发病病例。
我们将利用哥伦比亚脑库中存储的 100 例早发 AD 病例,全部
相同的 PSEN1[E280A] 突变,以确定由于观察到的全部病理学
单基因缺陷并将这些数据与散发性老年发病疾病进行比较。一些
该银行的哥伦比亚人进行了淀粉样蛋白和 tau PET 研究。散发性疾病时
在老年人中,与衰老相关的大脑变化很频繁,并且在缺乏他们的情况下
明确的界限,仅针对该疾病的显性遗传形式的治疗可能是
无效。可能区分和促进老年人 AD 的因素包括炎症、
脑血管系统受损、小胶质细胞过度增生、细胞老化(例如细胞分裂)
核膜,因此 TDP-43 从细胞核中逃逸,可能
突触核蛋白的贡献。我们将通过以下方式探讨这些因素与衰老的相互作用:
描述性神经病理学和实验神经病理学方法。比较将利用
来自几个脑库的零星 AD 尸检。这些研究包括最先进的
单细胞 RNAseq 和炎症标记物的高级评估。蜂窝模型将是
使用人类诱导多能干细胞衍生的神经元进行探索,这些神经元含有
PSEN1[E280A] 突变,旨在发现受 PSEN1[E280A] 突变影响的下游途径
突变。与小胶质细胞共培养,以捕获小胶质细胞的自主和非自主效应
突变将被确定。
为了实现这些目标,我们组建了一支具有长期经验的多机构国际团队
合作历史。洛佩拉博士是第一个认识这些家庭并管理该家庭的人
阿尔茨海默病预防试验是美国国立卫生研究院支持的项目哥伦比亚团队的负责人。支持
在神经病理学方面,我们聘请了 Eric Huang 博士的专业知识。科西克几乎有
与 Lopera 合作 30 年,熟悉哥伦比亚的研究开展情况
最近与 Eric Huang 一起参观了哥伦比亚脑库。科西克紧密相连
通过与 Bruce 一起担任 Tau 联盟联合董事,与 UCSF 建立了机构关系
磨坊主。 Kosik 曾与 Ellisman 合作发表文章,并担任国家实验室审查委员会成员
加州大学圣地亚哥分校显微镜和成像研究中心。因此,该项目包括
强大、经验丰富且高度整合的团队能够执行复杂的项目
处理不可避免出现的任何障碍。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PSEN1 E280A Cholinergic-like Neurons and Cerebral Spheroids Derived from Mesenchymal Stromal Cells and from Induced Pluripotent Stem Cells Are Neuropathologically Equivalent.
PSEN1 E280A胆碱能神经元和源自间充质基质细胞和诱导多能干细胞的脑球体是神经病理学上等效的。
- DOI:10.3390/ijms24108957
- 发表时间:2023-05-18
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome.
- DOI:10.1016/j.neulet.2019.03.032
- 发表时间:2019-06-11
- 期刊:
- 影响因子:2.5
- 作者:Mendivil-Perez M;Velez-Pardo C;Kosik KS;Lopera F;Jimenez-Del-Rio M
- 通讯作者:Jimenez-Del-Rio M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Stephen KOSIK其他文献
KENNETH Stephen KOSIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Stephen KOSIK', 18)}}的其他基金
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10327251 - 财政年份:2021
- 资助金额:
$ 259.11万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10679282 - 财政年份:2021
- 资助金额:
$ 259.11万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10579696 - 财政年份:2021
- 资助金额:
$ 259.11万 - 项目类别:
A novel approach to restricting the spread of neurofibrillary tau
限制神经原纤维 tau 蛋白扩散的新方法
- 批准号:
10478173 - 财政年份:2021
- 资助金额:
$ 259.11万 - 项目类别:
The complex interaction between Alzheimer drivers and aging
阿尔茨海默病驱动因素与衰老之间复杂的相互作用
- 批准号:
9892174 - 财政年份:2019
- 资助金额:
$ 259.11万 - 项目类别:
Project 2: Tau uptake mechanisms and neuronal excitability in FTD
项目 2:FTD 中的 Tau 摄取机制和神经元兴奋性
- 批准号:
10011930 - 财政年份:2016
- 资助金额:
$ 259.11万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7634459 - 财政年份:2007
- 资助金额:
$ 259.11万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
8084139 - 财政年份:2007
- 资助金额:
$ 259.11万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7879951 - 财政年份:2007
- 资助金额:
$ 259.11万 - 项目类别:
Development of RNAi as Treatment for Neurodegeneration
RNAi 治疗神经退行性疾病的发展
- 批准号:
7234487 - 财政年份:2007
- 资助金额:
$ 259.11万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 259.11万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 259.11万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 259.11万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 259.11万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 259.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 259.11万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 259.11万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 259.11万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 259.11万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 259.11万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




